Novobind Revenue and Competitors

Claim your profile

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Novobind's estimated annual revenue is currently $2.3M per year.(i)
  • Novobind's estimated revenue per employee is $155,000

Employee Data

  • Novobind has 15 Employees.(i)
  • Novobind grew their employee count by -12% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$2.4M3111%$40MN/A
#2
$0.2M20%N/AN/A
#3
$3.1M2033%N/AN/A
#4
$11.5M744%N/AN/A
#5
$2.2M29-12%$89.5MN/A
#6
$2.5M167%N/AN/A
#7
$22.3M144-6%N/AN/A
#8
$3.4M22-8%N/AN/A
#9
$3.6M23N/AN/AN/A
#10
$23.3M15015%N/AN/A

NovoBind is an integrated animal health company utilizing next-generation biologics to target and neutralize key pathogens affecting producers and food safety. We target pathogens that cause >$1B of production losses and have been materially affected by the following: 1) Antibacterial resistance, 2) A Regulatory ban on antibiotics, and; 3) Changing consumer sentiment.

keywords:N/A

N/A

Total Funding

15

Number of Employees

$2.3M

Revenue (est)

-12%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.7M157%$4.4M
#2
$1.3M157%N/A
#3
$1.3M15N/AN/A
#4
$1.3M15-17%N/A
#5
$1.3M15-6%N/A